Atlantic Coastal Acquisition Corp II

Atlantic Coastal Acquisition Corp. II operates as a capital pool company. It was formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was founded in May 2021 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK , Oct. 18, 2023 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special purpose acquisition corporation, announced that Atlantic Coastal Acquisition Management II LLC, the Company's initial public offering sponsor (the "Sponsor"), has deposited $80,000 into the Company's trust account (the "Trust Account) in order to extend the period of time that the Company has to complete a business combination for an additional one (1) month period, from October 19, 2023 to November 19, 2023. In exchange for the Sponsor's additional contribution to the Trust Account, the Company issued a convertible promissory note to the Sponsor in an aggregate principal amount of $80,000.

Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account

WOBURN, Mass. & NEW YORK--(BUSINESS WIRE)--Abpro Corporation (“Abpro”), a biotechnology company with the mission of improving the lives of those facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB), a special purpose acquisition corporation (“Atlantic Costal”), today announced a term sheet to enter into a definitive business combination, which was entered into on September 18, 2023. The transaction is expec.

Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II

Atlantic Coastal Acquisition Corp. II raised $300 million in an IPO in January 2022.

Atlantic Coastal Acquisition Corp. II Is 2nd SPAC Aimed At Mobility

NEW YORK, March 4, 2022 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (the "Company") announced that, commencing March 7, 2022, holders of the units sold in the Company's initial public offering may elect to separately trade the shares of the Company's Series A common stock and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Atlantic Coastal Acquisition Corp. II Announces the Separate Trading of its Shares of Series A Common Stock and Warrants Commencing March 7, 2022

News for Atlantic Coastal Acquisition Corp II Stock (ACAB)